Diabetic Kidney disease Clinical Trial (Pro Kidney)

Mohamed A. El-Shahawy, MD, MPH, MHA, FASN, CPI

Director and Principal Investigator

Clinical Professor of Medicine (Adjunct), Keck School of Medicine of USC

Trial Overview

The Diabetic Kidney disease Clinical trial Protocol is a Phase 3 clinical trial aiming at in addition to evidence-based standard of care in patients with diabetic kidney disease (diabetic nephropathy).

Key Inclusion Criteria

  1. Age
    • 30 to 80 years old at the time of informed consent
  2. Diagnosis
    • Documented type 2 diabetes mellitus (T2DM)
    • Documented chronic kidney disease (CKD) due to T2DM
      (Renal biopsy not required)
  3. Kidney Function (eGFR)
    • eGFR 20 to 35 ml/min/1.73m²

Why Join This Clinical Trial?

– Access to highly experienced Board certified Nephrologists

– Participation is voluntary, and you will learn all details about the protocol by Contacting with our clinical team contact us.

– Clinical trials offer additional care options for your condition, with access to new medicines at no cost.

– Help move science forward and improve human health, wellbeing, and quality of life.

– No cost to participate.

Compensation

– For each Kidney biopsy Procedure the patient will be paid $ 500 and for each visit $ 250.

– If the patient completes all 24 visits, including the three procedures (biopsy and injections), they will receive a total of $6,000.

– After completing the 24 protocol visits, patients will have follow-up visits every 12 weeks until ProKidney reaches the protocol endpoints and concludes the trial. Each visit will be compensated at $250.

-Free Transportation will be provided

Connect with Our Clinical Team